Order Article Reprints

Tolmeijer SH, Koornstra RHT, de Groot JWB, Geerlings MJ, van Rens DH, Boers-Sonderen MJ, Schalken JA, Gerritsen WR, Ligtenberg MJL, Mehra N. Plasma BRAF Mutation Detection for the Diagnostic and Monitoring Trajectory of Patients with LDH-High Stage IV Melanoma. Cancers. 2021; 13(15):3913. https://doi.org/10.3390/cancers13153913

Tolmeijer, Sofie H., Rutger H. T. Koornstra, Jan Willem B. de Groot, Maartje J. Geerlings, Dirk H. van Rens, Marye J. Boers-Sonderen, Jack A. Schalken, Winald R. Gerritsen, Marjolijn J. L. Ligtenberg, and Niven Mehra. 2021. "Plasma BRAF Mutation Detection for the Diagnostic and Monitoring Trajectory of Patients with LDH-High Stage IV Melanoma" Cancers 13, no. 15: 3913. https://doi.org/10.3390/cancers13153913

Tolmeijer, S. H., Koornstra, R. H. T., de Groot, J. W. B., Geerlings, M. J., van Rens, D. H., Boers-Sonderen, M. J., Schalken, J. A., Gerritsen, W. R., Ligtenberg, M. J. L., & Mehra, N. (2021). Plasma BRAF Mutation Detection for the Diagnostic and Monitoring Trajectory of Patients with LDH-High Stage IV Melanoma. Cancers, 13(15), 3913. https://doi.org/10.3390/cancers13153913